SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

CymaBay Therapeutics, Inc. CBAY NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

CymaBay Therapeutics, Inc. (CBAY) has 12 identified peers for comparison in the Healthcare sector. Peers include ABOS, ACLX, AKRO, BMEA, DAWN, ETNB and others.

CBAY has a market capitalization of $3.73B, compared to an average peer market cap of $2.95B.

Peers & Similar Companies — CBAY

Acumen Pharmaceuticals, Inc.

$2.68 +6.77% $162.34M

$114.89 +0.02% $6.72B

Akero Therapeutics, Inc.

$54.65 0.00% $4.5B

Biomea Fusion, Inc.

$1.95 +3.72% $116.02M

Day One Biopharmaceuticals, Inc.

$21.46 -0.14% $2.22B

$14.84 0.00% $2.2B

Homology Medicines, Inc.

$0.93 +0.77% $3.02M

Gossamer Bio, Inc.

$0.43 +7.74% $101.29M

Structure Therapeutics Inc.

$53.19 -1.95% $3.06B

Inozyme Pharma, Inc.

$4.00 +0.25% $258.25M

Kiniksa Pharmaceuticals, Ltd.

$46.92 -0.80% $3.48B

Karuna Therapeutics, Inc.

$329.83 +0.03% $12.6B

People Also View

Karuna Therapeutics, Inc.

Madrigal Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc.

Akero Therapeutics, Inc.

Viking Therapeutics, Inc.

Kiniksa Pharmaceuticals, Ltd.

Structure Therapeutics Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message